-+ 0.00%
-+ 0.00%
-+ 0.00%

NUVECTIS PHARMA - NXP200 GRANTED BREAKTHROUGH THERAPY DESIGNATION BY CHINA CDE FOR BRAF V600-MUTANT GLIOMA

路透·09/24/2026 12:02:52

请登录查看新闻详情